Prakash Guha of Zuventus Healthcare in close competition with Mankind Pharma's Rajeev Juneja for the coveted Dynamic Entrepreneur Award at 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013
With an aptly theme of Incredible Pharmaleaders, Billion Dreams - Pushing India's growth Agenda organized by Network 7 Media Group's Pharmaleaders ( www.pharmaleaders.tv ), Asia's most analytical news media in healthcare communications at the historic 6th Annual Pharmaceutical Leadership Summit Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com ), the nomination voting category of Dynamic Entrepreneur of the year Award 2013 has intensified with less than three days to go when the voting closes to chose the winner in the coveted title where india's top five dynamic leaders in healthcare domain has made their stunning performance in the last one year. In the race to the coveted Dynamic Entrepreneur Award 2013 title are Suresh Sugavanam,MD, UL (Underwriters Laboratories), Vilas Gandhi Tewari, Director, USV Ltd, Rajeev Juneja, Co-Founder & Director, Mankind Pharma Ltd, Ashish Shah, MD, QSI Healthcare, Prakash Guha, MD, Zuventus Healthcare Ltd.
The Indian pharmaceutical industry currently ranks third in terms of volume of production (10% of global share) and is the 14th largest by value (1.5%). Its turnover has grown from a mere $0.3 billion in 1980 to about $21.73 billion in 2009-10. The industry consists of more than 5,000 small, medium and large manufacturers. The domestic market is valued at $9.44 billion, while pharmaceutical exports in 2009-10 amounted to some $8.79 billion in value terms. Industry is facing a difficult times as the new price regime is halting the pace of drugmakers & host of other issues like regulatory challenges, clinical trials & faulty policy logzam by the government. Against the background of the prevailing medical practice & market conditions, the image of pharma companies are of utmost importance says Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders, " the leadership style of all these five nominees has been spectacular & each leader has a unique style in meeting the challenges & leading the team from front. These Leaders have demonstrated remarkable display of maintaining the growth momentum despite the difficult times".
While Suresh Sugavanam,MD, UL (Underwriters Laboratories) is leading one of the world's largest Conformity Assessment Service Provider backed by more than a century of experience in product testing and inspection. UL has assessed, tested or inspected billions of products, systems and processes. A key part of UL's mission is to foster quality assurance and improvement whilst maintaining UL's reputation for professionalism and integrity. UL has established a wholly owned subsidiary in India in 1998. Vilas Gandhi Tewari, Director, USV Ltd is spearheading a portfolio which consists of Solid Orals, Injectables, Ophthalmics, Biosimilars, Biologicals Reagents, Peptides, APIs and Custom Peptide Services. USV is No. 1 in the OAD market by Rx and by value and No. 1 in Cardiology by Rx. It is important to note that Glycomet, Glycomet GP, Pioz, Pioz MF,Glynase and Glynase MF are ranked 1st in their respective categories. Rajeev Juneja, Co-Founder & Director, Mankind Pharma Ltd is leading the 7th largest Pharmaceutical Company of India incepted in 1995 with a meagre capital of? ?50 lakhs and 20 employees. Today, Mankind are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of INR 3000 crores. Ashish Shah, MD, QSI Healthcare .Ashish Shah is the Managing Director of QSI Healthcare, leading operations from the Bangalore Innovation Center. In his more than 20 years of experience in the healthcare industry, he has been passionate about the deployment of new technologies, developing products that exceed customer's expectations, and building world-class teams that drive business growth. Ashish was previously with the healthcare divisions within Siemens and GE. He has led global technology teams that range from 100 to 1300+ engineers. Ashish has also led work on mergers and acquisitions, change management initiatives and global innovation projects. He also has expertise in developing global organizations, providing a variety of growth strategy solutions.The dynamic & ambitious Prakash Guha, MD, Zuventus Healthcare Ltd is credited with Crossing the enviable 100 Cr turn over mark in just 18 months of operations & building Mega brands which made it into Top 300 industry brands in less than 5 years of our existence & achieving leadership positions for some brands displacing even well entrenched MNC brands. Today Zuventus Healthcare has a strong network of Medical Representatives on a pan india basis, state of Maufacturing facilities & turnover of more than 650 Crore with a strong basket of products.
Read more: http://www.indiaprwire.com/pressrelease/health-care/20131223277568.htm